îæ€çŽ¢
îæ€çŽ¢
î
Molecular Partners AG
MOLNîãŠã©ãããªã¹ãã«è¿œå
4.300USD
+0.040+0.94%
çµå€Â 09-23 16:00ïŒETïŒ
160.82Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
Molecular Partners AGã«ã€ã㊠äŒæ¥å
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
Molecular Partners AG ãããã£ãŒã«
îäŒæ¥ã³ãŒãMOLN
äŒç€ŸåMolecular Partners AG
äžå Žæ¥Oct 22, 2014
æé«çµå¶è²¬ä»»è
ãCEOãAmstutz (Patrick)
åŸæ¥å¡æ°159
蚌åžçš®é¡Depository Receipt
決ç®ææ«Oct 22
æ¬ç€Ÿæåšå°Wagistrasse 14
éœåžSCHLIEREN
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœSwitzerland
éµäŸ¿çªå·8952
é»è©±çªå·41447557700
ãŠã§ããµã€ãhttps://www.molecularpartners.com/
äŒæ¥ã³ãŒãMOLN
äžå Žæ¥Oct 22, 2014
æé«çµå¶è²¬ä»»è
ãCEOãAmstutz (Patrick)
Molecular Partners AGã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Michael Tobias Stumpp, Ph.D.
Dr. Michael Tobias Stumpp, Ph.D.
Executive Vice President - Projects, Member of the Management Board
Executive Vice President - Projects, Member of the Management Board
--
--
Dr. Patrick Amstutz, Ph.D.
Dr. Patrick Amstutz, Ph.D.
Chief Executive Officer, Executive Director, Member of the Management Board
Chief Executive Officer, Executive Director, Member of the Management Board
--
--
Mr. William M. (Bill) Burns
Mr. William M. (Bill) Burns
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Sandip S. Kapadia, CPA
Mr. Sandip S. Kapadia, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Vito J. Palombella, Ph.D.
Dr. Vito J. Palombella, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Michael Vasconcelles, M.D.
Dr. Michael Vasconcelles, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Agnete B. Fredriksen, Ph.D.
Dr. Agnete B. Fredriksen, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Dominik Hoechli, M.D.
Dr. Dominik Hoechli, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Renate Gloggner
Ms. Renate Gloggner
Executive Vice President - People and Community, Member of the Management Board
Executive Vice President - People and Community, Member of the Management Board
--
--
Mr. Alexander Zuercher
Mr. Alexander Zuercher
Chief Operating Officer, Member of the Management Board
Chief Operating Officer, Member of the Management Board
--
--
詳现ãèŠã
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Michael Tobias Stumpp, Ph.D.
Dr. Michael Tobias Stumpp, Ph.D.
Executive Vice President - Projects, Member of the Management Board
Executive Vice President - Projects, Member of the Management Board
--
--
Dr. Patrick Amstutz, Ph.D.
Dr. Patrick Amstutz, Ph.D.
Chief Executive Officer, Executive Director, Member of the Management Board
Chief Executive Officer, Executive Director, Member of the Management Board
--
--
Mr. William M. (Bill) Burns
Mr. William M. (Bill) Burns
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Sandip S. Kapadia, CPA
Mr. Sandip S. Kapadia, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Vito J. Palombella, Ph.D.
Dr. Vito J. Palombella, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Michael Vasconcelles, M.D.
Dr. Michael Vasconcelles, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
ãããã質å
Molecular Partners AGã®äžäœ5åã®æ ªäž»ã¯èª°ã§ããïŒ
îMolecular Partners AGã®äžäœ5åã®æ ªäž»ã¯ä»¥äžã®ãšããã§ããDr. Michael Tobias Stumpp, Ph.D.
Molecular Partners AGïŒMOLNïŒã®æ ªåŒãä¿æããŠããæ©é¢ã®æ°ã¯ããã€ã§ããïŒ
î2026Q1æç¹ã§ãMolecular Partners AGã®æ ªåŒãä¿æããŠããæ©é¢ã¯14瀟ãããä¿ææ ªåŒã®ç·åžå ŽäŸ¡å€ã¯çŽ3.59Mã§ãå
šäœã®9.60%ãå ããŠããŸãã2025Q4ãšæ¯èŒããŠãæ©é¢ã®æã¡æ ªã¯-12188.00å¢å ããŠããŸãã